Metabolically 'extremely unhealthy' obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study.
Cardiovascular events
Diabetes
Extremely unhealthy
Non-obese
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
18
09
2023
accepted:
10
11
2023
medline:
4
12
2023
pubmed:
4
12
2023
entrez:
4
12
2023
Statut:
aheadofprint
Résumé
Non-obese patients with diabetes mellitus (DM) are becoming more prevalent, but their cardiovascular risk (CV) especially when accompanied with cardio-renal-metabolic co-morbidities (hypertension, chronic kidney disease, hyperlipidemia) is not well characterised. The aim of the study was to assess the CV risk among patients with DM in relation to obesity and cardio-renal-metabolic co-morbidities. This was a cohort study of all patients with DM without a history of major adverse cardiovascular event who were hospitalized for any reason in France in 2013 with at least 5 years of follow-up. They were categorized by the presence of obesity vs no obesity, as well as three cardio-renal-metabolic co-morbidities: hypertension, chronic kidney disease, hyperlipidemia. 'Extremely unhealthy' patients with DM were defined as those having all 3 co-morbidities. There were 196,112 patients (mean age 65.7 (SD 13.7) years; 54.3% males) included into the analysis. During a mean follow-up of 4.69 ± 1.79 years, when adjusted for multiple covariates, the non-obese and 'extremely unhealthy' obese patients had the highest risk of CV death [aHR 1.40 (95% CI, 1.22-1.61) and 1.48 (95% CI, 1.25-1.75), respectively]. The 'extremely unhealthy' obese had the highest risk of MACE-HF [aHR 1.84 (95% CI, 1.72-1.97)] and new-onset AF [aHR 1.64 (95% CI, 1.47-1.83)]. Both non-obese and obese patients with DM with associated cardio-renal-metabolic co-morbidities are an 'extremely unhealthy' phenotype with the highest risk of CV death and CV events.
Sections du résumé
BACKGROUND
BACKGROUND
Non-obese patients with diabetes mellitus (DM) are becoming more prevalent, but their cardiovascular risk (CV) especially when accompanied with cardio-renal-metabolic co-morbidities (hypertension, chronic kidney disease, hyperlipidemia) is not well characterised. The aim of the study was to assess the CV risk among patients with DM in relation to obesity and cardio-renal-metabolic co-morbidities.
MATERIALS AND METHODS
METHODS
This was a cohort study of all patients with DM without a history of major adverse cardiovascular event who were hospitalized for any reason in France in 2013 with at least 5 years of follow-up. They were categorized by the presence of obesity vs no obesity, as well as three cardio-renal-metabolic co-morbidities: hypertension, chronic kidney disease, hyperlipidemia. 'Extremely unhealthy' patients with DM were defined as those having all 3 co-morbidities.
RESULTS
RESULTS
There were 196,112 patients (mean age 65.7 (SD 13.7) years; 54.3% males) included into the analysis. During a mean follow-up of 4.69 ± 1.79 years, when adjusted for multiple covariates, the non-obese and 'extremely unhealthy' obese patients had the highest risk of CV death [aHR 1.40 (95% CI, 1.22-1.61) and 1.48 (95% CI, 1.25-1.75), respectively]. The 'extremely unhealthy' obese had the highest risk of MACE-HF [aHR 1.84 (95% CI, 1.72-1.97)] and new-onset AF [aHR 1.64 (95% CI, 1.47-1.83)].
CONCLUSION
CONCLUSIONS
Both non-obese and obese patients with DM with associated cardio-renal-metabolic co-morbidities are an 'extremely unhealthy' phenotype with the highest risk of CV death and CV events.
Identifiants
pubmed: 38047924
doi: 10.1007/s00392-023-02344-8
pii: 10.1007/s00392-023-02344-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Ridderstråle M, Gudbjörnsdottir S, Eliasson B, Nilsson PM, Cederholm J (2006) Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 259(3):314–322
doi: 10.1111/j.1365-2796.2006.01617.x
pubmed: 16476109
Wu J, Feng Z, Duan J, Li Y, Deng P, Wang J et al (2023) Global burden of type 2 diabetes attributable to non-high body mass index from 1990 to 2019. BMC Public Health 23(1):1338
doi: 10.1186/s12889-023-15585-z
pubmed: 37438808
pmcid: 10337097
Adesoba TP, Brown CC (2023) Trends in the Prevalence of Lean Diabetes Among U.S. Adults, 2015–2020. Diabetes Care. 46(4):885–9
doi: 10.2337/dc22-1847
pubmed: 36763508
Ruderman NB, Schneider SH, Berchtold P (1981) The, “metabolically-obese”, normal-weight individual. Am J Clin Nutr 34(8):1617–1621
doi: 10.1093/ajcn/34.8.1617
pubmed: 7270486
Luis G, Weissman NJ, Ron W, Shmuel F, Regina D, Ellen PE et al (2002) The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 39(4):578–84
doi: 10.1016/S0735-1097(01)01802-2
Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-DeHoff RM, Zhou Q et al (2007) Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120(10):863–870
doi: 10.1016/j.amjmed.2007.05.011
pubmed: 17904457
Hainer V, Aldhoon-Hainerová I (2013) Obesity paradox does exist. Diabetes Care. 36(Suppl 2):S276–S281
doi: 10.2337/dcS13-2023
pubmed: 23882059
pmcid: 3920805
Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE et al (2002) The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39(4):578–584
doi: 10.1016/S0735-1097(01)01802-2
pubmed: 11849854
Carnethon MR, De Chavez PJD, Biggs ML, Lewis CE, Pankow JS, Bertoni AG et al (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308(6):581–590
doi: 10.1001/jama.2012.9282
pubmed: 22871870
pmcid: 3467944
Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A et al (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36(4):887–893
doi: 10.2337/dc12-0944
pubmed: 23139375
pmcid: 3609520
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J et al (2014) Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation 130(24):2143–2151
doi: 10.1161/CIRCULATIONAHA.114.009098
pubmed: 25378546
pmcid: 4302029
Tsujimoto T, Kajio H, Sugiyama T (2016) Risks for cardiovascular and cardiac deaths in nonobese patients with diabetes and coronary heart disease. Mayo Clin Proc 91(11):1545–1554
doi: 10.1016/j.mayocp.2016.08.018
pubmed: 27729109
Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A et al (2014) Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab 16(4):317–325
doi: 10.1111/dom.12217
pubmed: 24118783
Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, Willett WC et al (2014) Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 370(3):233–244
doi: 10.1056/NEJMoa1304501
pubmed: 24428469
pmcid: 3966911
Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES et al (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis a cohort study. Ann Intern Med 162(9):610–618
doi: 10.7326/M14-1551
pubmed: 25938991
Fauchier G, Bisson A, Bodin A, Herbert J, Semaan C, Angoulvant D et al (2021) Metabolically healthy obesity and cardiovascular events: a nationwide cohort study. Diabetes Obes Metab 23(11):2492–2501
doi: 10.1111/dom.14492
pubmed: 34251088
Thomas MC, Zimmet P, Shaw JE (2006) Identification of obesity in patients with type 2 diabetes from Australian primary care: the NEFRON-5 study. Diabetes Care 29(12):2723–2725
doi: 10.2337/dc06-1288
pubmed: 17130212
Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JPH, Pinkney JH (2006) Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 82(966):280–284
doi: 10.1136/pmj.2005.039032
pubmed: 16597817
pmcid: 2579635
Hauguel-Moreau M, Hergault H, Cazabat L, Pépin M, Beauchet A, Aïdan V et al (2023) Prevalence of prediabetes and undiagnosed diabetes in a large urban middle-aged population: the CARVAR 92 cohort. Cardiovasc Diabetol 22(1):31
doi: 10.1186/s12933-023-01761-3
pubmed: 36782164
pmcid: 9926717
Diederichs C, Berger K, Bartels DB (2011) The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 66(3):301–311
doi: 10.1093/gerona/glq208
pubmed: 21112963
Arnold SV, Kosiborod M, Wang J, Fenici P, Gannedahl G, LoCasale RJ (2018) Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry. Diabetes Obes Metab 20(8):2000–2003
doi: 10.1111/dom.13303
pubmed: 29577540
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al (2015) Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1 9 million people. Lancet Diabetes Endocrinol 3(2):105–113
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L et al (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138(1):24–32
doi: 10.7326/0003-4819-138-1-200301070-00008
pubmed: 12513041
Vidra N, Trias-Llimós S, Janssen F (2019) Impact of obesity on life expectancy among different European countries: secondary analysis of population-level data over the 1975–2012 period. BMJ Open 9(7):e028086
doi: 10.1136/bmjopen-2018-028086
pubmed: 31371290
pmcid: 6678519
Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J et al (2006) Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis Off J Natl Kidney Found 48(3):392–401
doi: 10.1053/j.ajkd.2006.05.021
Matsushita K, Ballew SH, Wang AY-M, Kalyesubula R, Schaeffner E, Agarwal R (2022) Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol 18(11):696–707
Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L et al (2018) Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J 39(5):397–406
doi: 10.1093/eurheartj/ehx448
pubmed: 29020414
Kim YG, Han K-D, Choi J-I, Boo KY, Kim DY, Oh S-K et al (2019) The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study. Cardiovasc Diabetol 18(1):128
doi: 10.1186/s12933-019-0932-z
pubmed: 31575379
pmcid: 6774211
Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL et al (2010) Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 25(8):853–858
doi: 10.1007/s11606-010-1340-y
pubmed: 20405332
pmcid: 2896589
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367
doi: 10.1161/01.CIR.0000136587.68725.8E
pubmed: 15249509
Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N et al (2021) Obstructive sleep apnea and cardiovascular disease: a scientific statement from the american heart association. Circulation 144(3):e56–e67
doi: 10.1161/CIR.0000000000000988
pubmed: 34148375
Song X, Tabák AG, Zethelius B, Yudkin JS, Söderberg S, Laatikainen T et al (2014) Obesity attenuates gender differences in cardiovascular mortality. Cardiovasc Diabetol 13(1):144
doi: 10.1186/s12933-014-0144-5
pubmed: 25928355
pmcid: 4212094
Ball J, Løchen M-L, Wilsgaard T, Schirmer H, Hopstock LA, Morseth B, et al. sex differences in the impact of body mass index on the risk of future atrial fibrillation: insights from the longitudinal population-based tromsø study
Malmborg M, Schmiegelow MDS, Nørgaard CH, Munch A, Gerds T, Schou M et al (2020) Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? Eur Heart J 41(13):1346–1353
doi: 10.1093/eurheartj/ehz913
pubmed: 31860067
Singleton MJ, German CA, Soliman EZ, Whalen SP, Bhave PD, Bertoni AG et al (2020) Body mass index, sex, and incident atrial fibrillation in diabetes: The ACCORD trial. Clin Electrophysiol 6(13):1713–1720
doi: 10.1016/j.jacep.2020.08.008
Field M, Kuduvalli M, Torella F, McKay V, Khalatbari A, Lip GYH (2022) Integrated care systems and the aortovascular hub. Thromb Haemost 122(2):177–180
doi: 10.1055/a-1591-8033
pubmed: 34407555